| Product Code: ETC8978439 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Pharmacogenetic Testing Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Romania Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Romania Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Romania Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Rising awareness about the benefits of pharmacogenetic testing |
4.2.3 Technological advancements in the healthcare sector |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing |
4.3.2 Lack of standardized guidelines for pharmacogenetic testing |
4.3.3 Concerns about data privacy and security |
5 Romania Pharmacogenetic Testing Market Trends |
6 Romania Pharmacogenetic Testing Market, By Types |
6.1 Romania Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Romania Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Romania Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Romania Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Romania Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Romania Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Romania Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Romania Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Romania Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Romania Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Romania Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Romania Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Romania Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Romania Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Romania Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Romania Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Romania Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Romania Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Romania Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Romania Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Romania Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Romania Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Romania Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Romania Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Romania Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Romania Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Romania Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Romania Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Romania Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Romania Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Romania Pharmacogenetic Testing Market Export to Major Countries |
7.2 Romania Pharmacogenetic Testing Market Imports from Major Countries |
8 Romania Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing among healthcare providers |
8.2 Number of research studies and publications related to pharmacogenetic testing in Romania |
8.3 Investment in infrastructure for pharmacogenetic testing facilities |
9 Romania Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Romania Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Romania Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Romania Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Romania Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Romania Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Romania Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Romania Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Romania Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Romania Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Romania Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here